Hamrick Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42K Sell
35
-100
-74% -$102K 0.03% 100
2026
Q1
$124K Buy
135
+100
+286% +$101K 0.07% 108
2025
Q4
$37.6K Buy
+35
New +$33.5K 0.03% 95

Other funds holding LLY

Hamrick Investment Counsel's LLY Position: Q2 2026 in Review

Hamrick Investment Counsel reduced its Eli Lilly (LLY) stake by 74% in Q2 2026, selling an estimated $102K and leaving 35 shares worth $42K. The position accounts for 0.03% of the portfolio, ranked #100.

Hamrick Investment Counsel first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $124K in Q1 2026. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hamrick Investment Counsel held 35 shares of Eli Lilly worth $42K as of Q2 2026.
  • Hamrick Investment Counsel sold 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.03% of Hamrick Investment Counsel's portfolio in Q2 2026, its #100 holding.
  • Hamrick Investment Counsel first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Hamrick Investment Counsel's Eli Lilly position peaked at $124K in Q1 2026.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.